Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program. [electronic resource]
Producer: 20060901Description: 5690-9 p. digitalISSN:- 0264-410X
- Bacteremia -- economics
- Cost-Benefit Analysis
- Heptavalent Pneumococcal Conjugate Vaccine
- Humans
- Immunity, Herd
- Immunization Programs -- economics
- Markov Chains
- Meningitis, Pneumococcal -- economics
- Meningococcal Vaccines -- administration & dosage
- Norway
- Pneumococcal Infections -- economics
- Pneumococcal Vaccines -- administration & dosage
- Vaccination -- economics
- Vaccines, Conjugate -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.